Avenue Supermarts Grants 50,000 Stock Options Under Employee Stock Option Scheme 2023

1 min read     Updated on 02 May 2026, 09:12 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Avenue Supermarts Limited granted 50,000 stock options to an employee under its ESOP Scheme 2023 on 2nd May, 2026, priced at Rs. 4,080 per option. The options are categorized as Class A (vesting 1st September, 2032) and Class B (vesting 1st September, 2029), with a three-month exercise period post-vesting. This grant is part of the 1,500,000 options approved by shareholders in August 2023.

powered bylight_fuzz_icon
39282156

*this image is generated using AI for illustrative purposes only.

Avenue Supermarts Limited's Nomination and Remuneration Committee has approved the grant of 50,000 stock options to an employee under the company's Employee Stock Option Scheme 2023. The approval was granted during the committee's meeting held on 2nd May, 2026, as disclosed to the stock exchanges under Regulation 30 of SEBI regulations.

Stock Option Grant Details

The granted options are structured under two distinct categories with different vesting timelines and conditions:

Parameter: Details
Total Options Granted: 50,000
Grant Date: 2nd May, 2026
Exercise Price: Rs. 4,080 per option
Face Value per Share: Rs. 10
Exercise Period: 3 months from vesting date

Vesting Schedule and Categories

The options are divided into two classes with separate vesting dates:

Option Class: Vesting Date
Class A Options: 1st September, 2032
Class B Options: 1st September, 2029

The vesting of these options will be subject to the option grantee meeting various performance parameters as determined by the Nomination and Remuneration Committee under the ESOP Scheme 2023.

Scheme Framework and Compliance

The Employee Stock Option Scheme 2023 operates in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Each option granted can be converted into one fully paid-up equity share of the company.

The shareholders had previously approved the grant of up to 1,500,000 options to eligible employees of the company and subsidiary companies during the Annual General Meeting held on 10th August, 2023. Prior to this current grant, the company had already issued:

  • 1,237,250 options on 1st September, 2023
  • 125,000 options on 13th January, 2024

Exercise Terms and Conditions

Once vested, the option holder will have a three-month window to exercise the options by paying Rs. 4,080 per option. The exercise is contingent upon meeting the performance parameters established by the committee at the time of vesting.

The disclosure was made pursuant to SEBI regulations and the master circular dated 30th January, 2026, ensuring transparency in the company's employee benefit programs and stock option activities.

Historical Stock Returns for Avenue Supermarts DMart

1 Day5 Days1 Month6 Months1 Year5 Years
-4.76%-3.40%+10.38%+4.96%+3.99%+53.09%

How will Avenue Supermarts' stock price performance over the next 3-6 years impact the attractiveness of these options given the Rs. 4,080 exercise price?

What specific performance parameters might the Nomination Committee set for the 2029 and 2032 vesting dates, and how could they align with D-Mart's expansion strategy?

Will Avenue Supermarts need to grant additional stock options beyond the remaining 137,750 available options to retain key talent in India's competitive retail sector?

Avenue Supermarts DMart
View Company Insights
View All News
like16
dislike

Avenue Supermarts announces director cessation and senior management restructuring effective May 2026

2 min read     Updated on 02 May 2026, 08:51 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Avenue Supermarts Limited announced the cessation of Independent Director Chandrashekhar Bhave on 16th May 2026 following completion of his second term. The company also implemented multiple senior management changes effective 2nd May 2026, including role transitions for Rohit Mundhra, Ravi Sharma, Hitesh Shah, and Stephen Thomas across operations, audit, and business oversight functions.

powered bylight_fuzz_icon
39280863

*this image is generated using AI for illustrative purposes only.

Avenue Supermarts Limited has announced significant leadership changes, including the cessation of an Independent Director and multiple senior management role transitions effective May 2026. The company communicated these changes to stock exchanges on 2nd May 2026, outlining both board-level and operational management restructuring.

Director Cessation

The Board of Directors took on record the conclusion of the second term of Mr. Chandrashekhar Bhave (DIN: 00059856) as an Independent Director on 16th May 2026. He will cease to hold office as an Independent Director with effect from the close of business hours on 16th May 2026. The Board placed on record their deep appreciation for the valuable contribution, guidance, and support rendered by Mr. Bhave during his tenure with the Company.

Parameter: Details
Director Name: Mr. Chandrashekhar Bhave
DIN: 00059856
Cessation Date: 16th May 2026
Reason: Completion of second tenure

Senior Management Changes

Based on the recommendation of the Nomination and Remuneration Committee, the Board approved several changes in Senior Management Personnel effective 2nd May 2026. These changes involve role transitions, additional responsibilities, and reporting structure modifications across key operational areas.

Key Personnel Transitions

Mr. Rohit Mundhra will transition from Internal Auditor to Regional Head - Operations (Rajasthan). Due to this change in role and reporting structure, he will cease to be Senior Management Personnel effective 2nd May 2026.

Mr. Ravi Sharma, currently Head - Risk and Compliance (Partner Ecosystem), will take on the additional role of Internal Auditor for financial year 2026-27. He will continue to be categorized as Senior Managerial Personnel. Mr. Sharma brings 35 years of leadership experience across automobile and retail sectors and has been associated with Avenue Supermarts for 17 years, having previously led finance and human resources functions.

Mr. Hitesh Shah, presently Head - Pharma Business, will assume oversight of Food Business in addition to Pharmacy Business. He will be re-designated as Chief Business Officer - Pharmacy and Food Services while continuing as Senior Managerial Personnel. Mr. Shah joined the company in March 2007 and has 36 years of experience across multiple industries.

Mr. Stephen Thomas, Head - Food Services, will report to Mr. Hitesh Shah and will cease to be Senior Managerial Personnel due to the change in his reporting structure.

Management Restructuring Overview

Personnel: Previous Role New Role/Status Effective Date
Rohit Mundhra Internal Auditor (SMP) Regional Head - Operations (Non-SMP) 2nd May 2026
Ravi Sharma Head - Risk & Compliance Additional role as Internal Auditor (SMP) 2nd May 2026
Hitesh Shah Head - Pharma Business Chief Business Officer - Pharmacy & Food (SMP) 2nd May 2026
Stephen Thomas Head - Food Services (SMP) Reports to Hitesh Shah (Non-SMP) 2nd May 2026

These organizational changes reflect the company's strategic approach to operational efficiency and management structure optimization. The transitions maintain continuity while redistributing responsibilities across key business functions including operations, audit, compliance, and business development.

Historical Stock Returns for Avenue Supermarts DMart

1 Day5 Days1 Month6 Months1 Year5 Years
-4.76%-3.40%+10.38%+4.96%+3.99%+53.09%

Will Avenue Supermarts appoint a new Independent Director to replace Mr. Chandrashekhar Bhave, and what expertise will they prioritize in the selection process?

How might the consolidation of Pharmacy and Food Services under one Chief Business Officer impact D-Mart's expansion strategy in these segments?

Could these management restructuring changes signal preparation for accelerated store expansion or entry into new geographical markets?

Avenue Supermarts DMart
View Company Insights
View All News
like18
dislike

More News on Avenue Supermarts DMart

1 Year Returns:+3.99%